EKF Diagnostics (LON:EKF) Share Price Passes Above 200-Day Moving Average of $28.14

EKF Diagnostics Holdings plc (LON:EKFGet Free Report) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 28.14 ($0.35) and traded as high as GBX 28.76 ($0.35). EKF Diagnostics shares last traded at GBX 28 ($0.34), with a volume of 132,645 shares.

EKF Diagnostics Price Performance

The company has a quick ratio of 1.77, a current ratio of 1.82 and a debt-to-equity ratio of 1.02. The stock’s 50-day moving average price is GBX 26.95 and its 200-day moving average price is GBX 28.14. The company has a market capitalization of £127.04 million, a price-to-earnings ratio of -933.33 and a beta of 0.62.

EKF Diagnostics Announces Dividend

The company also recently disclosed a dividend, which will be paid on Friday, December 1st. Investors of record on Thursday, November 2nd will be given a GBX 1.20 ($0.01) dividend. The ex-dividend date is Thursday, November 2nd. This represents a yield of 4.59%. EKF Diagnostics’s payout ratio is -3,333.33%.

About EKF Diagnostics

(Get Free Report)

EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.

Further Reading

Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.